ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Dimethylamine → 3-(Dimethylamino)-1-(2-thienyl)-1-propanone

HRID 1686171
印刷

反応式

HRID 1686171 の反応式
[C:1]([C:4]1[S:5][CH:6]=[CH:7][CH:8]=1)(=[O:3])[CH3:2].[CH2:9]=O.[CH3:11][NH:12][CH3:13]>>[CH3:11][N:12]([CH3:9])[CH2:13][CH2:2][C:1]([C:4]1[S:5][CH:6]=[CH:7][CH:8]=1)=[O:3]
参加物実験手順出典と根拠反応ノート

参加物

4

反応物 3

HCID 674DimethylamineHCID 712FormaldehydeHCID 69202-Acetylthiophene

生成物 1

HCID 4082573-(Dimethylamino)-1-(2-thienyl)-1-propanone

実験手順

In this example, 2-acetylthiophene is used as the starting material for reacting with formaldehyde and dimethylamine to form a Mannich product namely 3-dimethylamino-1-(2-thienyl)propan-1-one. A hydride reduction is performed on this propanone to form corresponding 3-dimethylamino-1-(2-thienyl)propan-1-ol. The resulting propanol is then reacted with fluoronaphthalene to form N,N-dimethyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine. Subsequently, racemic Duloxetine® is obtained by demethylation of this propylamine. In this process, the yield of demethylation is very low, about 41%. In addition, Duloxetine® produced via this route is racemic. Resolution is therefore needed to obtain chiral Duloxetine which renders this process less competitive.

出典と根拠

ORDレコード
ord-0e616e41bd944bd28bb0c634dd4e634b
出典データセット
uspto-grants-2012_04
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08148549B2

反応ノート

このページの内容参加物実験手順出典と根拠反応ノート